Search

Search Results
Results 1681 - 1690 of 9443 for emergency medicine
  • Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Valdoxan intended for persons living in Australia.
  • Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Domion intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Xigduo XR intended for persons living in Australia.
  • News - 7 May 2026
    Malaria remains a threat to young children in refugee settlements, where displacement, temporary housing, and limited access to healthcare reduce the effectiveness of conventional prevention tools.
  • News - 4 May 2026
    An update to Canadian guidance on screening for high-risk drinking and alcohol use provides streamlined recommendations in CMAJ (Canadian Medical Association Journal) that authors hope will make it...
  • News - 4 May 2026
    AI's performance in diagnostic tasks exceeds that of physicians, indicating a shift towards integrating advanced models in real-world medical decision-making.
  • News - 30 Apr 2026
    The World Stroke Organization is warning that climate change poses an escalating threat to brain health, with extreme heat in particular increasing the risk of having a stroke and of patients dying...
  • News - 28 Apr 2026
    Initial prescriptions for medications affecting cognition, such as antipsychotics, are disproportionately likelier to come from acute and post-acute settings such as emergency rooms, hospitals and...
  • Drug - 22 Apr 2026
    Consumer Medicine Information (CMI) about Diphereline intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.